Total Payments
$3,584
2024 Payments
$779.32
Companies
31
Transactions
235
Medicare Patients
2,160
Medicare Billing
$164,895
Payment Breakdown by Category
Food & Beverage$3,584 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,584 | 235 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $562.28 | 45 | $0 (2024) |
| Amgen Inc. | $546.93 | 36 | $0 (2024) |
| Novo Nordisk Inc | $521.09 | 41 | $0 (2024) |
| PFIZER INC. | $415.82 | 22 | $0 (2024) |
| Merck Sharp & Dohme LLC | $253.64 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $250.74 | 17 | $0 (2023) |
| GlaxoSmithKline, LLC. | $219.40 | 8 | $0 (2023) |
| Abbott Laboratories | $88.45 | 4 | $0 (2022) |
| Lilly USA, LLC | $79.17 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $76.48 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $779.32 | 46 | PFIZER INC. ($214.55) |
| 2023 | $891.93 | 64 | Novo Nordisk Inc ($189.88) |
| 2022 | $1,159 | 77 | GlaxoSmithKline, LLC. ($187.61) |
| 2021 | $709.29 | 45 | Amgen Inc. ($216.05) |
| 2019 | $14.86 | 1 | Amarin Pharma Inc. ($14.86) |
| 2018 | $28.97 | 2 | Amarin Pharma Inc. ($28.97) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Obesity | ||||||
| 11/13/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: Narcoplepsy | ||||||
| 11/05/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Vaccines | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Obesity | ||||||
| 10/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: VACCINES | ||||||
| 10/01/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.24 | General |
| 09/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: VACCINE | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: VACCINES | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: VACCINE | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: VACCINES | ||||||
| 07/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: PAIN | ||||||
| 07/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: VACCINE | ||||||
| 07/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: VACCINES | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diabetes | ||||||
| 06/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 659 | 810 | $214,237 | $55,167 |
| 2022 | 13 | 688 | 856 | $215,254 | $56,395 |
| 2021 | 15 | 530 | 685 | $180,802 | $37,205 |
| 2020 | 8 | 283 | 323 | $75,652 | $16,128 |
Total Patients
2,160
Total Services
2,674
Medicare Billing
$164,895
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 197 | $63,237 | $15,952 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 192 | $41,856 | $11,111 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 81 | 81 | $34,101 | $9,670 | 28.4% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 35 | 61 | $27,511 | $5,399 | 19.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 15 | 44 | $14,212 | $3,363 | 23.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 38 | 38 | $11,286 | $2,656 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2023 | 17 | 17 | $7,157 | $2,055 | 28.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $4,250 | $1,798 | 42.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 29 | 30 | $4,800 | $1,217 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $870.00 | $852.60 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $2,640 | $708.00 | 26.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 35 | 35 | $2,170 | $314.51 | 14.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 21 | $147.00 | $71.61 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 224 | $48,832 | $14,600 | 29.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $31,996 | $9,324 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 86 | 109 | $34,989 | $8,505 | 24.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 84 | 84 | $24,948 | $6,218 | 24.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 24 | 81 | $26,163 | $5,569 | 21.3% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 25 | 46 | $15,272 | $3,210 | 21.0% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 21 | 32 | $15,168 | $3,065 | 20.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 30 | $5,100 | $1,978 | 38.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 32 | 38 | $6,080 | $1,552 | 25.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 37 | 37 | $1,110 | $1,060 | 95.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 57 | 57 | $3,762 | $1,024 | 27.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 28 | 28 | $1,736 | $242.00 | 13.9% |
About Ryan Coelho, PA-C
Ryan Coelho, PA-C is a Physician Assistant healthcare provider based in Montville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1043703200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Coelho, PA-C has received a total of $3,584 in payments from pharmaceutical and medical device companies, with $779.32 received in 2024. These payments were reported across 235 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,584).
As a Medicare-enrolled provider, Coelho has provided services to 2,160 Medicare beneficiaries, totaling 2,674 services with total Medicare billing of $164,895. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Montville, NJ
- Active Since 06/12/2018
- Last Updated 01/15/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1043703200
Products in Payments
- Otezla (Drug) $508.82
- PREVNAR 20 (Biological) $349.23
- JARDIANCE (Drug) $312.57
- VRAYLAR (Drug) $240.25
- SHINGRIX (Biological) $187.96
- UBRELVY (Drug) $181.55
- QULIPTA (Drug) $140.48
- Ozempic (Drug) $117.08
- JANUVIA (Drug) $103.28
- Wegovy (Drug) $97.54
- Rybelsus (Drug) $90.07
- GARDASIL (Biological) $79.27
- SPRAVATO (Drug) $76.48
- Cologuard Collection Kit (Device) $63.85
- Livalo (Drug) $58.62
- NURTEC ODT (Drug) $58.18
- BELSOMRA (Drug) $55.61
- ENTRESTO (Drug) $44.92
- Prolastin-C Liquid (Biological) $44.46
- Vascepa (Drug) $43.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.